Inhibition of alternative complement pathway opsonization by group A streptococcal M protein

The Journal of Infectious Diseases
P K PetersonP G Quie

Abstract

Group A streptococcal M protein is known to be antiphagocytic; however, the exact basis for this property has not been established. In this study the hypothesis was tested that cell wall--associated M protein inhibits phagocytosis by interfering with bacterial opsonization. Two strains of group A Streptococcus pyogenes, CS44 (M+) and CS64 (an M- variant of CS44), were radiolabeled, and after incubation in serum these organisms were exposed to human polymorphonuclear leukocytes. Phagocytosis was quantitated by measurement of leukocyte-associated radioactivity. The contributions of complement and of immunoglobulin to streptococcal opsonization were evaluated by use of serum from a variety of sources. The results revealed that the M- strain was efficiently opsonized via the alternative complement pathway in a relative absence of immunoglobulins. In contrast, the M+ strain was poorly opsonized by all sera tested. These findings suggest that streptococcal M protein in some way prevents bacterial opsonization via the alternative complement pathway and that this property of M protein may partly explain its antiphagocytic characteristic.

Citations

Jan 1, 1994·Springer Seminars in Immunopathology·Z Fishelson
Aug 14, 2003·Molecular Immunology·Hanna JarvaSeppo Meri
May 23, 2001·International Immunopharmacology·E GiannakisD L Gordon
Sep 12, 1991·The New England Journal of Medicine·A L Bisno
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R D HorstmannV A Fischetti
Apr 1, 1984·The Journal of Experimental Medicine·E WhitnackE H Beachey
Mar 1, 1983·Microbiological Reviews·S K Unny, B L Middlebrooks
Apr 1, 1982·The Journal of Clinical Investigation·E Whitnack, E H Beachey
Mar 21, 2007·Infection and Immunity·Kendra A HylandP Patrick Cleary
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eleni GiannakisDavid L Gordon
Aug 6, 2000·The Annals of Pharmacotherapy·N E Russell, R E Pachorek
Jun 1, 1989·Microbiological Reviews·B B Finlay, S Falkow
Mar 6, 1999·Microbiology and Molecular Biology Reviews : MMBR·W W Navarre, O Schneewind
Jul 1, 1989·Clinical Microbiology Reviews·V A Fischetti
Dec 1, 1985·Infection and Immunity·D E Wexler, P P Cleary

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.